Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	7.02B
Revenue (ttm)	6.45B
Net Income (ttm)	370.11M
Shares Out	85.00M
EPS (ttm)	4.35
PE Ratio	18.97
Forward PE	16.78
Dividend	2.52 (3.05%)
Ex-Dividend Date	Feb 11, 2025

Volume	207,465
Average Volume	220,055
Open	81.10
Previous Close	81.60
Day's Range	80.80 - 83.30
52-Week Range	65.80 - 98.20
Beta	0.10
RSI	72.02
Earnings Date	Mar 20, 2025

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marke...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2024, TADAWUL:4163's revenue was 6.45 billion, an increase of 12.36% compared to the previous year's 5.74 billion. Earnings were 370.11 million, an increase of 12.42%.